Josh Fine

Josh Fine has held various roles in finance and operations throughout their career. Starting as an intern at Leeb Brokerage Services in 2000, they progressed to Assistant Analyst at Capital Preservation Partners in 2006. Josh then moved on to more senior positions, including AVP at Emerging Growth Equities, Director at Scarsdale Equities LLC, and Finance and Operations at Icagen. Most recently, they served as the Chief Financial Officer at Cyclo Therapeutics, Inc. from June 2019.

Josh Fine attended Canterbury School for an unknown duration, and later graduated from Hartwick College in 2005 with a Bachelor of Science in Political Science, focusing on Economic Policy.